Kevin A. Serpa
Pfizer (United States)(US)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling, Synthesis of heterocyclic compounds, Pharmacological Receptor Mechanisms and Effects, Bioactive Compounds and Antitumor Agents
Most-Cited Works
- → Subtype-Selective N-Methyl-d-Aspartate Receptor Antagonists: Synthesis and Biological Evaluation of 1-(Heteroarylalkynyl)-4-benzylpiperidines(2000)110 cited
- → Subtype-Selective N-Methyl-d-aspartate Receptor Antagonists: Synthesis and Biological Evaluation of 1-(Arylalkynyl)-4-benzylpiperidines(1999)95 cited
- → Activity profile of pregabalin in rodent models of epilepsy and ataxia(2005)91 cited
- → Modulation of dopamine neuronal activity by glutamate receptor subtypes(1997)90 cited
- → Synthesis and Pharmacology of Benzoxazines as Highly Selective Antagonists at M4Muscarinic Receptors(2002)82 cited
- → Asenapine effects in animal models of psychosis and cognitive function(2009)48 cited
- → Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptide(1989)41 cited
- → Discovery of PF-00217830: Aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder(2011)27 cited
- → Further studies of antagonism of seizure development between concurrently developing kindled limbic foci in the rat(1982)27 cited
- → Discovery of a novel Kv7 channel opener as a treatment for epilepsy(2015)22 cited